TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/24 18:44 | 9/13/24 | BBIO | Bridgebio Pharma, Inc. | E9 | Financ | InvAdv | Investment Advice | Kkr Genetic Disorder L.P. | NY | T | S | -149,350 | 25.75 | 0 | -5,800 | -19 | 25,261 | I | |||||||||||||||
2/17/21 17:36 | 2/17/21 | BBIO | Bridgebio Pharma, Inc. | DE | Financ | InvAdv | Investment Advice | Kkr Genetic Disorder L.P. | NY | T | S | -208,617 | 60.47 | 0 | -3,450 | -10 | 31,061 | I | |||||||||||||||
6/1/20 17:15 | 5/28/20 | BBIO | Bridgebio Pharma, Inc. | DE | Financ | InvAdv | Investment Advice | Kkr Genetic Disorder L.P. | NY | T | S | -79,792 | 33.39 | 0 | -2,390 | -6 | 34,511 | I | |||||||||||||||
7/3/19 16:30 | 7/1/19 | BBIO | Bridgebio Pharma, Inc. | DE | Financ | InvAdv | Investment Advice | Kkr Genetic Disorder L.P. | NY | T | P.d | 45,001 | 17.00 | 0 | 2,647 | 8 | 36,901 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |